These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34736988)

  • 1. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
    Suffian IFBM; Al-Jamal KT
    Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
    Mohamed Suffian IFB; Wang JT; Hodgins NO; Klippstein R; Garcia-Maya M; Brown P; Nishimura Y; Heidari H; Bals S; Sosabowski JK; Ogino C; Kondo A; Al-Jamal KT
    Biomaterials; 2017 Mar; 120():126-138. PubMed ID: 28056402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and preliminary evaluation of hepatitis B core antigen virus like nanoparticles loaded with indocyanine green.
    Wang Y; Zhang Y; Yu Y; Ren L; Wang J; Cheng L; Jiang D; Guo X; Teng T; Luo X; Lv S; Wang X; Wang H; Shi X; Zhang H; Bi S
    Ann Transl Med; 2020 Dec; 8(24):1661. PubMed ID: 33490173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
    Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
    Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
    Liu D; Li B; Bi C; Qiao H; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced assembly and colloidal stabilization of primate erythroparvovirus 1 virus-like particles for improved surface engineering.
    Sánchez-Rodríguez SP; Morán-García Adel C; Bolonduro O; Dordick JS; Bustos-Jaimes I
    Acta Biomater; 2016 Apr; 35():206-14. PubMed ID: 26911883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.
    Shan W; Zhang D; Wu Y; Lv X; Hu B; Zhou X; Ye S; Bi S; Ren L; Zhang X
    Nanomedicine; 2018 Apr; 14(3):725-734. PubMed ID: 29275067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
    Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
    Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation of viral nanoparticles for targeted drug delivery in cancer therapy.
    Alvandi N; Rajabnejad M; Taghvaei Z; Esfandiari N
    J Drug Target; 2022 Feb; 30(2):151-165. PubMed ID: 34210232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
    Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
    J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
    Panda SK; Kapur N; Paliwal D; Durgapal H
    J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.
    Shao W; Paul A; Abbasi S; Chahal PS; Mena JA; Montes J; Kamen A; Prakash S
    Int J Nanomedicine; 2012; 7():1575-86. PubMed ID: 22619514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.
    Zhang Y; Liu Y; Zhang B; Yin S; Li X; Zhao D; Wang W; Bi J; Su Z
    Protein Expr Purif; 2021 Feb; 178():105747. PubMed ID: 32898688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
    Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
    Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical Coarse-Grained Strategy for Macromolecular Self-Assembly: Application to Hepatitis B Virus-Like Particles.
    Depta PN; Dosta M; Wenzel W; Kozlowska M; Heinrich S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particle-based nanocarriers as an emerging platform for drug delivery.
    Yuan B; Liu Y; Lv M; Sui Y; Hou S; Yang T; Belhadj Z; Zhou Y; Chang N; Ren Y; Sun C
    J Drug Target; 2023 Jun; 31(5):433-455. PubMed ID: 36940208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.